Thoracoscopic Lobectomy for Congenital Lung Lesions #MMPMID29127960
Moyer J; Lee H; Vu L
Clin Perinatol 2017[Dec]; 44 (4): 781-94 PMID29127960show ga
Congenital lung lesions (CLL) comprise a heterogeneous group of developmental and histologic entities often diagnosed on screening prenatal ultrasound. While large lesions can produce hemodynamic compromise and fetal nonimmue hydrops or neonatal respiratory distress, most fetuses with CLL proceed to uncomplicated term delivery and are asymptomatic at birth. The risk of developing malignancy and infectious complications drives the decision to prophylactically resect CLL in asymptomatic patients. Since first described in 2003, thoracoscopic lobectomy for CLL has been shown to provide decreased hospital length of stay and decreased time of tube thoracostomy when compared to open resection, without increased risk of perioperative morbidity. Additionally, recent advances in minimally invasive instrumentation promise to address some of the remaining challenges of thoracoscopic surgery in small infants and neonates. We describe our approach to minimally invasive lobectomy in children with CLL, post-operative care and management of procedure-specific complications.